|
MORE DETAILS
|
USEFUL READING
|
The following selected references from the past year or so should prove useful reading for everyone in MedComms. You will find a much more extensive collection of relevant headlines and links to news, views and opinions developing at our related MedCommsNews.com service.
|
|
|
Updated Pitching Code of Conduct Published by the HCA
Published by the Healthcare Communications Association (HCA), 19 September 2019
The HCA's updated Pitching Code of Conduct provides a best practice template to continue to support clients and agencies navigate the ever-changing pitch process. The code has been developed and updated with contribution from pharmaceutical representatives from marketing and communications and procurement, as well as healthcare communication agencies.
[Read on to find out more]
|
|
|
MPIP Tackles Barriers to Open Access Through Latest Initiatives
Published by Medical Publishing Insights and Practices (MPIP), 29 August 2019
Open access options can vary by funding source as well as by journal, and this information is not readily available on journal websites. To address this gap, MPIP created the Open Access Journal Tool for Industry (OA-JTI), a free and unique resource to help find open access publishing options for industry-sponsored research.
[Read on to find out more]
|
|
|
AMWA-EMWA-ISMPP joint position statement on predatory publishing
Published by Current Medical Research and Opinion, 29 July 2019
The American Medical Writers Association (AMWA), the European Medical Writers Association (EMWA) and the International Society for Medical Publication Professionals (ISMPP) recognize the challenges to scientific publishing being posed by predatory journals and their publishers, which employ practices undermining the quality, integrity and reliability of published scientific research. This joint position statement complements several other sets of guidelines that have helped define the characteristics of a predatory journal.
[Read on to find out more]
|
|
|
How to involve patients in medical publishing: insights from a patient advocate
Published by The Publication Plan, 22 July 2019
Simon Stones gives his view on the practical steps that patients, publishers and the pharmaceutical industry can take to boost patient involvement in research.
[Read on to find out more]
|
|
|
Access all areas?
Published by Research Fortnight, 10 July 2019
The pharmaceutical industry is embracing openness in publishing - it should also be pushing for more of it, says Chris Winchester.
[Read on to find out more]
|
|
|
Author Insights On: Transparency and Credibility of Industry-Sponsored Clinical Trial Publications: A Survey of Journal Editors
Published by The MAP newsletter, 14 June 2019
Over the past decade, we have seen an increasing demand for greater transparency in industry-sponsored research and the negative impact a lack of transparency can have on trust and credibility of published results.
[Read on to find out more]
|
|
|
Pharmaceutical industry launches new guidance on working with patients
Published by PharmaTimes, 14 June 2019
The Association of the British Pharmaceutical Industry (ABPI) has published a new guide for pharmaceutical companies working with patients, which provides companies with new guidance on "working successfully, collaboratively and ethically with patients and patient groups and in line with the ABPI Code of Practice.
[Read on to find out more]
|
|
|
We Need to Talk about PLS... Exploring the Opportunities of Plain-Language Summaries
Published by The MAP newsletter, 1 May 2019
Patients have the most to gain from the research and development of medicines. Their perspective on the development of new treatments is critical and should be valued alongside that of the investigator and sponsor.
[Read on to find out more]
|
|
|
From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
Published by PMLive.com, 18 April 2019
In 2014, the European Medicines Agency (EMA) gave the first indication that layperson summaries of the results of pharma-sponsored clinical trials would become part of their mandatory requirements.
[Read on to find out more]
|
|
|
Meeting report: summary of day 2 of the 2019 European ISMPP Meeting
Published by The Publication Plan, 7 February 2019
The 2019 European Meeting of the International Society for Medical Publication Professionals (ISMPP) was held in London on 22-23 January and attracted more than 300 delegates; the highest number of attendees to date. A summary of the second day of the meeting is provided.
[Read on to find out more]
|
|
|
Meeting report: summary of day 1 of the 2019 European ISMPP Meeting
Published by The Publication Plan, 31 January 2019
The 2019 European Meeting of the International Society for Medical Publication Professionals (ISMPP) was held in London on 22-23 January and attracted more than 300 delegates; the highest number of attendees to date. A summary of the first day of the meeting is provided.
[Read on to find out more]
|
|
|
Rare Diseases: How to Develop an Effective Publication Strategy
Published by the MAP newsletter, 30 January 2019
Eleanor Thurtle, Annabel Griffiths, and Danielle Sheard of Costello Medical, Cambridge, UK, write about the various challenges and conundrums are associated with strategic publication planning in rare diseases.
[Read on to find out more]
|
|
|
Whenever, wherever - the new face of flexible working
Published by PMLive, 28 January 2019
Anna Korving argues that flexible, agile, dynamic or smart working is now one of the key differentiators for agency employers.
[Read on to find out more]
|
|
|
Pharmaceutical companies follow public funders of research in efforts to reform science publishing
Published by The BMJ, 25 January 2019
The author, Richard Smith, writes that "Funders of research are the one group who have the power to change the slow, inefficient, old-fashioned, wasteful, arbitrary, and, some would say, iniquitous way that we publish science."
[Read on to find out more]
|
|
|
Ipsen commits to making all its published scientific research freely accessible to everyone
Published by Ipsen, 21 January 2019
Ipsen announces that "From January 2019, our aim is to publish all Ipsen-affiliated research "open access". Open access means that the article will be openly accessible online and free of cost or other barriers."
[Read on to find out more]
|
|
|
Global ban on pharma freebies, including cultural gifts
Published by PMLive.com, 14 January 2019
A newly updated global code of practice for the pharmaceutical industry has come into force, banning the offering of gifts and promotional aids around the world.
[Read on to find out more]
|
|
|
Plan S: The Ambitious Initiative to End the Reign of Paywalls
Published by The Scientist, 19 December 2018
Diana Kwon describes how a funder-driven push for freely accessible scholarly literature has divided the scientific community.
[Read on to find out more]
|
|
|
Open Access: What Transparency Means to Me
Published by MPIP, 19 November 2018
Martin Delahunty, former Global Director within the Open Research Group of Springer Nature, shares a publisher's perspective on open access. Martin provides the historical context surrounding the rise of open access publishing and his insights on where the open access movement is headed. He also discusses the role of open access in facilitating transparency, scientific understanding, and credibility.
[Read on to find out more]
|
|
|
Medical Writers Worth Their Weight in Gold
Published by The MAP Newsletter, 14 November 2018
The question of how much value professional medical writers add to the development of medical publications has arisen regularly over the past couple of decades, and recent studies have aimed to provide an answer.
[Read on to find out more]
|
|
|
The art of storytelling in clinical data communication - what we can learn from Batman and the Joker?
Published by pharmaphorum, 3 October 2018
Our decisions and behaviours are based on stories - the stories people tell themselves or the ones that others tell them. So how can we harness the power of storytelling to effectively communicate clinical data?
[Read on to find out more]
|
|
|
Connected opinion leaders: Pharma's new go-to professional influencers
Published by Medical Marketing and Media, 5 September 2018
Laura Entis reflects on the importance of the growing number of physicians who are savvy on social media and whom other clinicians enjoy reading for concise takes on trends, research, or new products.
[Read on to find out more]
|
|
WHAT ELSE?
|
DID YOU MISS #MEDCOMMS DAY 2019?
12 June 2019
It was a busy 8th annual celebration of A Day in the Life of #MedComms.
Supported by
Media Contacts
Once again we had contributions from across the globe, from Auckland in New Zealand to San Francisco in the USA, providing great insights into the #MedComms working day.
See what happened at MedCommsDay.com
|
|
|
|
|
|
|
SPECIALIST MEDCOMMS JOBS
We're listing hundreds of job opportunities for specialists in medical communications, medical education and medical publishing at NextMedCommsJob
|
|
|
|
|
|
|
The MedComms Workbook helps freelancers and clients find each other within the specialist medical communications, education and publishing communities.
Learn more here.
|
|
|
